December 11, 2025—Medtronic announced that the Onyx liquid embolic system (LES)—Onyx 18 and Onyx 34—is now indicated in the United States for embolization of the middle meningeal artery (MMA) as an ...

Delcath Systems, Inc. announced the publication of a retrospective study reporting outcomes from patients with liver-dominant ...

Teleflex Incorporated announced it has entered into definitive agreements to sell the company’s acute care, interventiona ...

The purpose of this commentary is to critically examine the CREST-2 results, discuss their implications for clinical decision-making for asymptomatic carotid artery disease, and guide clinicians ...

Bendit Technologies, an Israel-based developer of a steerable microcatheter platform, announced that the FDA has granted ...

Biocoat, Inc. announced the formation of Surmodics Services & Technologies, a newly named division of Surmodics, Inc. that ...

Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the ...

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...

Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeG ...

Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...

In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD), ...